Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage (Q33426745)

26 July 2017

Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage (English)

1 reference

26 July 2017

0 references

1 reference

Florent Delbos

1

1 reference

26 July 2017

Gérald Bertrand

2

1 reference

26 July 2017

Laure Croisille

3

1 reference

26 July 2017

Hélène Ansart-Pirenne

4

1 reference

26 July 2017

Philippe Bierling

5

1 reference

26 July 2017

Cécile Kaplan

6

1 reference

26 July 2017

7 September 2015

1 reference

26 July 2017

1 reference

26 July 2017

56

1 reference

26 July 2017

1

1 reference

26 July 2017

59-66; quiz 58

1 reference

Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group

26 July 2017

1 reference

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage

21 January 2018

1 reference

HLA-DRw52a is involved in alloimmunization against PL-A1 antigen

21 January 2018

1 reference

Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201

21 January 2018

1 reference

Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia

21 January 2018

1 reference

Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis

21 January 2018

1 reference

Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia

21 January 2018

1 reference

Antenatal treatment of neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulin

21 January 2018

1 reference

Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?

21 January 2018

1 reference

Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure

21 January 2018

1 reference

HLA typing using bead-based methods.

21 January 2018

1 reference

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

21 January 2018

1 reference

Formulas for fetal weight estimation by ultrasound measurements based on neonatal specific gravities and volumes

21 January 2018

1 reference

Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry

21 January 2018

1 reference

Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases

21 January 2018

1 reference

Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes

21 January 2018

1 reference

Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism

21 January 2018

1 reference

Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity

21 January 2018

1 reference

The immune response to the HPA-1a antigen: association with HLA-DRw52a

21 January 2018

1 reference

Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489).

21 January 2018

1 reference

Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia

21 January 2018

1 reference

The role of HLA antibodies in neonatal thrombocytopenia: a prospective study

21 January 2018

1 reference

HLA antibodies and fetomaternal alloimmune thrombocytopenia: myth or meaningful?

21 January 2018

1 reference

HLA antibodies and neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies

21 January 2018

1 reference

21 January 2018

1 reference

Alloimmune neonatal neutropenia and thrombocytopenia associated with maternal anti HNA-1a, HPA-3b and HLA antibodies

21 January 2018

1 reference

Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective

21 January 2018

1 reference

Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke.

21 January 2018

1 reference

Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells

21 January 2018

1 reference

Expression of a single-chain human leukocyte antigen-DRA/DRB3*01:01 molecule and differential binding of a monoclonal antibody in the presence of specifically bound human platelet antigen-1a peptide.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.13274

1 reference

26 July 2017

1 reference